StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.05−0.04 (-3.67%)

Close on Nov 13, 2026Market cap $12.96MP/E –Yield –

Pluri total assets

Total assets on the balance sheet at the end of each period.

Pluri's total assets was $24.93M at Sep 30, 2026. For fiscal 2026 it was $24.88M, down 35.7% from the year before. Over ten years it grew -5.9% a year on average. The highest annual figure on record is $93.54M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$24.88M-35.7%
FY2025Jun 30, 2025$38.68M-2.1%
FY2024Jun 30, 2024$39.53M-22.2%
FY2023Jun 30, 2023$50.80M-25.4%
FY2022Jun 30, 2022$68.07M-27.2%
FY2021Jun 30, 2021$93.54M+42.7%
FY2020Jun 30, 2020$65.53M+109.3%
FY2019Jun 30, 2019$31.31M-19.6%
FY2018Jun 30, 2018$38.96M+3.8%
FY2017Jun 30, 2017$37.53M-18.3%
FY2016Jun 30, 2016$45.94M-32.6%
FY2015Jun 30, 2015$68.16M-7.9%
FY2014Jun 30, 2014$74.02M+8.4%
FY2013Jun 30, 2013$68.32M+44.1%
FY2012Jun 30, 2012$47.42M+3.1%
FY2011Jun 30, 2011$46.02M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$24.93M-26.0%
Q4 FY2026CQ2 2026Jun 30, 2026$24.88M-35.7%
Q3 FY2026CQ1 2026Mar 31, 2026$26.06M-30.3%
Q2 FY2026CQ4 2025Dec 31, 2025$30.60M-0.9%
Q1 FY2026CQ3 2025Sep 30, 2025$33.67M-5.0%
Q4 FY2025CQ2 2025Jun 30, 2025$38.68M-2.1%
Q3 FY2025CQ1 2025Mar 31, 2025$37.41M+2.8%
Q2 FY2025CQ4 2024Dec 31, 2024$30.86M-25.8%
Q1 FY2025CQ3 2024Sep 30, 2024$35.44M-20.4%
Q4 FY2024CQ2 2024Jun 30, 2024$39.53M-22.2%
Q3 FY2024CQ1 2024Mar 31, 2024$36.39M-35.3%
Q2 FY2024CQ4 2023Dec 31, 2023$41.56M-30.6%
Q1 FY2024CQ3 2023Sep 30, 2023$44.54M-25.5%
Q4 FY2023CQ2 2023Jun 30, 2023$50.80M-25.4%
Q3 FY2023CQ1 2023Mar 31, 2023$56.24M-28.9%
Q2 FY2023CQ4 2022Dec 31, 2022$59.93M-26.2%
Q1 FY2023CQ3 2022Sep 30, 2022$59.75M-28.6%
Q4 FY2022CQ2 2022Jun 30, 2022$68.07M-27.2%
Q3 FY2022CQ1 2022Mar 31, 2022$79.13M-0.1%
Q2 FY2022CQ4 2021Dec 31, 2021$81.18M+55.3%
Q1 FY2022CQ3 2021Sep 30, 2021$83.75M+42.1%
Q4 FY2021CQ2 2021Jun 30, 2021$93.54M+42.7%
Q3 FY2021CQ1 2021Mar 31, 2021$79.17M+243.9%
Q2 FY2021CQ4 2020Dec 31, 2020$52.26M+110.2%
Q1 FY2021CQ3 2020Sep 30, 2020$58.95M+113.8%
Q4 FY2020CQ2 2020Jun 30, 2020$65.53M+109.3%
Q3 FY2020CQ1 2020Mar 31, 2020$23.02M+22.9%
Q2 FY2020CQ4 2019Dec 31, 2019$24.86M+2.3%
Q1 FY2020CQ3 2019Sep 30, 2019$27.57M-10.7%
Q4 FY2019CQ2 2019Jun 30, 2019$31.31M-19.6%
Q3 FY2019CQ1 2019Mar 31, 2019$18.73M-56.4%
Q2 FY2019CQ4 2018Dec 31, 2018$24.30M-45.7%
Q1 FY2019CQ3 2018Sep 30, 2018$30.89M-0.2%
Q4 FY2018CQ2 2018Jun 30, 2018$38.96M+3.8%
Q3 FY2018CQ1 2018Mar 31, 2018$42.97M-1.3%
Q2 FY2018CQ4 2017Dec 31, 2017$44.73M+38.5%
Q1 FY2018CQ3 2017Sep 30, 2017$30.95M–
Q4 FY2017CQ2 2017Jun 30, 2017$37.53M–
Q3 FY2017CQ1 2017Mar 31, 2017$43.54M–
Q2 FY2017CQ4 2016Dec 31, 2016$32.30M–

More Pluri figures

See a number that looks wrong?